You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Using Technology to Improve Clinical Counseling of Adolescent Risky Behaviors

    SBC: POSSIBILITIES FOR CHANGE LLC            Topic: NIDA

    DESCRIPTION (provided by applicant): The goal of this SBIR is to develop an innovative adolescent primary health care delivery model for use in primary care that overcomes barriers of health care provider time, skill and teen engagement when providing effective tobacco use reduction counseling. This will be achieved by creating a web-based counseling module that will provide interactive, technolog ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Microfabricated Cochlear Electrode Arrays

    SBC: MEMStim LLC            Topic: NIDCD

    DESCRIPTION (provided by applicant): In the USA, about 36 million adults suffer from hearing loss and three out of every 1,000 children are born deaf or hard-of-hearing. When conventional hearing aids provide no appreciable benefit, implantable electronicdevices using electrode arrays inside the cochlea are a viable solution. With these cochlear implants, the profoundly deaf achieve reasonable wor ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Glycosaminoglycans to Treat and Prevent Radiation-Induced Oral Mucositis

    SBC: GLYCOMIRA, LLC            Topic: NIDCR

    DESCRIPTION (provided by applicant): GlycoMira Therapeutics has developed safe and effective anti-inflammatory glycosaminoglycan derivatives and proposes to test the feasibility of using its lead compound to treat or prevent oral mucositis. Mucositis is acommon and debilitating complication of cancer treatment. Cancer patients undergoing radiation or chemotherapy often develop this painful inflam ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Development of a Porcine Model of Autosomal Dominant Polycystic Kidney Disease

    SBC: EXEMPLAR GENETICS, LLC            Topic: NIDDK

    DESCRIPTION (provided by applicant): Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common, potentially fatal genetic disorders in humans with an incidence of 1 in every 500-1000 individuals. The majority of ADPKD cases (85%) are caused by mutations in the PKD1 gene, which encodes polycystin-1. ADPKD is a systemic disorder that often leads to kidney failure and extrarenal ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Advanced Bactericidal Urinary Catheters Based on Electromodulated Nitric Oxide Release

    SBC: BIOCREDE INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): We propose a completely new, low cost and robust bactericidal urinary 100% silicone Foley catheter with a gt3-6 month shelf-life, that will utilize electromodulated delivery of nitric oxide (NO) for up to 45-60 d to serve as a potent antimicrobial/antibiofilm agent. The first generation device will possess a stable inorganic nitrit salt reservoir within on lume ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Therapeutic Use of mTOT Modulators in Polycystic Kidney Disease

    SBC: Metabolic Solutions Development Company, LLC            Topic: NIDDK

    ? DESCRIPTION (provided by applicant): Polycystic kidney disease (PKD) is a term applied to a group of inherited disorders characterized by the presence of cysts in the kidney although multiple organs are typically affected. Renal pathologies found inessentially all forms of PKD include increased fluid secretion, matrix remodeling, cellular proliferation, and apoptosis, with a altered differen ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  7. Sterculic Acid Analogs to Inhibit Macular Degeneration

    SBC: L2 DIAGNOSTICS LLC            Topic: NEI

    ABSTRACT The long-term product goal of this project is a small molecule therapeutic for choroidal neovascularization (CNV, the hallmark of wet age-related macular degradation), an abnormal growth of blood vessels in the choroid layer of the eye that results in damage to the retina and consequent blindness. Our lead compound is the natural product sterculic acid, which has been shown to inhibit ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  8. System for Multiplex Protein:Protein Interaction Studies Modeled with Antibodies

    SBC: AXIOMX INC            Topic: NIGMS

    DESCRIPTION (provided by applicant): The overarching goal of Phase I is to produce a method that will generate, identify and clone a catalog of protein-protein interactions in a single rapid experiment. In this proposal we will model the technology using antibody-antigen interactions. Recombinant antibody libraries against a proteome could be produced prior to any need, and then desired affinity r ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Copper Nanoparticle Impregnated, Nitric Oxide Generating Hollow Fibers for Artifi

    SBC: MEDARRAY INC            Topic: NHLBI

    DESCRIPTION (provided by applicant): More than 190,000 people suffer from acute respiratory distress syndrome (ARDS) in the US each year, with mortality rates from 25-40% with the best treatment. In addition, there are over 12 million patients with chronic lung disease. These patients typically have 1-3 acute exacerbations of their disease state per year that cause additional short term respirat ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Patient Breath Simulator for Capnometer Performance Verification

    SBC: WITTING INNOVATION LLC            Topic: NHLBI

    DESCRIPTION (provided by applicant): Capnometers can fail in a number of ways that are not detectable using current static calibration testing procedures. These failures could include leaks in the sample line, a weak sample pump, inadequate dynamic response, flow restriction and flow obstruction. Failure of a capnometer during critical care procedures such as sedation and anesthesia can be life th ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government